抗生物質市場：作用機序、薬剤クラス別、スペクトル、カテゴリー、用途、投与経路、流通チャネル別-2025-2030年世界予測

抗生物質市場は、2023年に430億8,000万米ドルと評価され、2024年には457億4,000万米ドルに達すると予測され、CAGR 6.81％で成長し、2030年には683億5,000万米ドルに達すると予測されています。

抗生物質市場には、細菌を死滅させる、または細菌の増殖を阻害することで細菌感染と闘う薬剤の調査が含まれます。その範囲には、βラクタム系、テトラサイクリン系、マクロライド系、アミノグリコシド系など様々なクラスが含まれ、ヒトの健康、獣医学的使用、農業目的での用途に及ぶ。抗生物質の必要性は、細菌性疾患の治療、感染症の蔓延防止、公衆衛生の保護に重要な役割を果たすことから生じており、特に手術、がん治療、パンデミック時の予防薬として不可欠です。最終用途は、病院、診療所、在宅ヘルスケアから畜産まで幅広く、抗生物質では生産性の向上や家畜の健康保護が行われています。細菌感染の増加、ヘルスケアの向上による新興市場での需要の高まり、耐性株と闘う抗生物質製剤の技術革新が成長を後押ししています。潜在的な機会は、ナロースペクトラムの開発、新規抗菌剤のためのバイオテクノロジーの活用、抗生物質の使用をより正確に調整する迅速診断技術への投資にあります。しかし、抗生物質耐性、規制上のハードル、抗生物質生産の収益性低下などの課題が市場拡大の妨げとなっています。また、多剤耐性菌の出現につながる抗生物質の乱用や誤用、耐性菌の原因となる家畜への抗生物質の使用をめぐる議論などの限界もあります。イノベーションに関しては、抗菌ペプチドの研究、免疫療法との相乗効果の調査、AIを活用した創薬に注力することで、業界の成長につなげることができます。技術革新に有効な分野としては、耐性を破る分子の開発や、抗生物質配備の精度を向上させるための次世代シークエンシング技術などがあり、技術主導の変革が可能な市場であることを示唆しています。このように、抗生物質市場は多くの課題に直面しているが、イノベーションと規制当局との連携に戦略的に注力することで、この重要なヘルスケア分野における持続的成長と市場開拓の道を開くことができます。

市場力学：急速に進化する抗生物質市場の主要市場インサイトを公開

抗生物質市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の感染症および慢性疾患の流行増加
  • 疾病の早期診断・治療への傾斜
  • 新規の抗生物質試験開発のための臨床試験数の増加
• 市場抑制要因
  • 抗生物質耐性に関する懸念
• 市場機会
  • 抗生物質耐性の微生物感染症を治療するための先進的なプロスペクト分子と新規併用療法
  • 新薬開発のための研究開発と投資の拡大
• 市場の課題
  • 抗生物質の使用による副作用

ポーターの5つの力：抗生物質市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：抗生物質市場における外部からの影響の把握

外部マクロ環境要因は、抗生物質市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析抗生物質市場における競合情勢の把握

抗生物質市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス抗生物質市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、抗生物質市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨抗生物質市場における成功への道筋を描く

抗生物質市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で感染症や慢性疾患の蔓延が増加
    • 病気の早期診断と治療への傾向
    • 新規医薬品開発のための臨床試験数の増加抗生物質

試験

• 抑制要因
  • 抗生物質耐性に関連する懸念
• 機会
  • 抗生物質耐性微生物感染症を治療するための先進的な有望分子と新しい併用療法
  • 新薬開発のための研究開発と投資の増加
• 課題
  • 抗生物質の使用による副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 抗生物質市場アクションメカニズム

• 細胞壁合成阻害剤
• DNA合成阻害剤
• ミコール酸阻害剤
• タンパク質合成阻害剤
• RNA合成阻害剤

第7章 抗生物質市場薬剤クラス別

• アミノグリコシド
• カルバペネム
• セファロスポリン
• フルオロキノロン
• マクロライド
• ペニシリン
• スルホンアミド

第8章 抗生物質市場スペクトラム

• 幅広い抗生物質
• 狭域スペクトル抗生物質

第9章 抗生物質市場：カテゴリ別

• ブランド抗生物質
• 一般的な抗生物質

第10章 抗生物質市場：用途別

• 耳の感染症
• 胃腸感染症
• 呼吸器感染症
• 敗血症
• 皮膚感染症
• 尿路感染症

第11章 抗生物質市場：投与経路別

• オーラル
• 非経口

第12章 抗生物質市場：流通チャネル別

• オフライン
• オンライン

第13章 南北アメリカの抗生物質市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域の抗生物質市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの抗生物質市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Amneal Pharmaceuticals LLC
• Astellas Pharma, Inc.
• Bausch Health Companies, Inc.
• Bayer AG
• Bristol-Myers Squibb Company
• Cadila Healthcare Ltd.
• Dr. Reddy's Laboratories
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Glenmark Pharmaceuticals Limited
• Hetero Healthcare
• Johnson & Johnson Services, Inc.
• KYORIN Holdings, Inc.
• Lupin Limited
• Melinta Therapeutics, Inc.
• Merck & Co., Inc.
• MerLion Pharmaceuticals GmbH
• Mylan N.V. by Viatris
• Novartis International AG
• Pfizer Inc.
• Sanofi S.A.
• Shionogi & Co., Ltd.
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. ANTIBIOTICS MARKET RESEARCH PROCESS
• FIGURE 2. ANTIBIOTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 23. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 28. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 29. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANTIBIOTICS MARKET DYNAMICS
• TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANTIBIOTICS MARKET SIZE, BY BRANDED ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY GENERIC ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY EAR INFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ANTIBIOTICS MARKET SIZE, BY SEPTICEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ANTIBIOTICS MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL ANTIBIOTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL ANTIBIOTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL ANTIBIOTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 63. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 64. CANADA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 65. CANADA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 66. CANADA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. CANADA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. CANADA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 100. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 101. CHINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 102. CHINA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 103. CHINA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. CHINA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 105. CHINA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 107. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 108. INDIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 109. INDIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 110. INDIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. INDIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. INDIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 147. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 154. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 161. TAIWAN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. THAILAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 175. VIETNAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 190. DENMARK ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 197. EGYPT ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 204. FINLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 211. FRANCE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 218. GERMANY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 225. ISRAEL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 226. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 227. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 228. ITALY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 229. ITALY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 230. ITALY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. ITALY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 232. ITALY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 239. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 246. NIGERIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 253. NORWAY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 254. POLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 255. POLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 256. POLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 257. POLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 258. POLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. POLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 260. POLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 261. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 262. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 263. QATAR ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 264. QATAR ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 265. QATAR ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 266. QATAR ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 267. QATAR ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 274. RUSSIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 281. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 288. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 295. SPAIN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 302. SWEDEN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 309. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 316. TURKEY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 323. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 329. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 330. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 331. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 332. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Antibiotics Market was valued at USD 43.08 billion in 2023, expected to reach USD 45.74 billion in 2024, and is projected to grow at a CAGR of 6.81%, to USD 68.35 billion by 2030.

The antibiotics market encompasses the investigation of drugs that combat bacterial infections by either killing bacteria or hindering their growth. Its scope includes various classes such as beta-lactams, tetracyclines, macrolides, aminoglycosides, and others, spanning applications in human health, veterinary use, and agricultural purposes. The necessity for antibiotics arises from their crucial role in treating bacterial diseases, preventing the spread of infections, and safeguarding public health, notably essential in surgeries, cancer treatment, and as prophylaxis during pandemics. End-use scopes range widely from hospitals, clinics, and home healthcare settings to animal husbandry, where antibiotics enhance productivity and safeguard livestock health. Growth is propelled by increasing bacterial infections, rising demand in emerging markets due to improved healthcare, and innovations in antibiotic formulations combating resistant strains. Potential opportunities lie in the development of narrow-spectrum antibiotics, leveraging biotechnology for novel antimicrobial agents, and investing in rapid diagnostic technologies that tailor antibiotic use more precisely. However, challenges such as antibiotic resistance, regulatory hurdles, and the decline in antibiotic production profitability impede market expansion. Limitations include the overuse and misuse of antibiotics, leading to the emergence of multi-drug-resistant organisms, and debates surrounding the use of antibiotics in livestock contributing to resistance. For innovation, focus on research in antimicrobial peptides, exploring synergies with immunotherapy, and leveraging AI for drug discovery can steer industry growth. Viable areas for innovation include developing resistance-breaking molecules and next-generation sequencing technology to improve precision in antibiotic deployment, suggesting a market poised for technologically driven transformation. Thus, while the antibiotics market encounters numerous challenges, strategic focus on innovation and regulatory collaboration can open pathways for sustainable growth and development in this critical healthcare sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antibiotics Market

The Antibiotics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of infectious and chronic diseases worldwide
  • Inclination toward early diagnosis and treatment of diseases
  • Rise in the number of clinical trials for the development of novel antibiotics trials
• Market Restraints
  • Concerns associated with antibiotics resistance
• Market Opportunities
  • Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
  • Growing in R&D and investments for the development of new drugs
• Market Challenges
  • Side effects caused by the usage of antibiotic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Antibiotics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antibiotics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antibiotics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antibiotics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antibiotics Market

A detailed market share analysis in the Antibiotics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antibiotics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antibiotics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antibiotics Market

A strategic analysis of the Antibiotics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antibiotics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., Bausch Health Companies, Inc., Bayer AG, Bristol-Myers Squibb Company, Cadila Healthcare Ltd., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Glenmark Pharmaceuticals Limited, Hetero Healthcare, Johnson & Johnson Services, Inc., KYORIN Holdings, Inc., Lupin Limited, Melinta Therapeutics, Inc., Merck & Co., Inc., MerLion Pharmaceuticals GmbH, Mylan N.V. by Viatris, Novartis International AG, Pfizer Inc., Sanofi S.A., Shionogi & Co., Ltd., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antibiotics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Action Mechanism, market is studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors.
• Based on Drug Class, market is studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides.
• Based on Spectrum, market is studied across Broad-spectrum Antibiotics and Narrow-spectrum Antibiotics.
• Based on Category, market is studied across Branded Antibiotics and Generic Antibiotics.
• Based on Application, market is studied across Ear Infection, Gastrointestinal Infections, Respiratory Infections, Septicemia, Skin Infections, and Urinary Tract Infections.
• Based on Route of Administration, market is studied across Oral and Parenteral.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
    • 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
    • 5.1.1.3. Rise in the number of clinical trials for the development of novel antibiotics

trials

• 5.1.2. Restraints
  • 5.1.2.1. Concerns associated with antibiotics resistance
• 5.1.3. Opportunities
  • 5.1.3.1. Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
  • 5.1.3.2. Growing in R&D and investments for the development of new drugs
• 5.1.4. Challenges
  • 5.1.4.1. Side effects caused by the usage of antibiotic drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Antibiotics Market, by Action Mechanism

• 6.1. Introduction
• 6.2. Cell Wall Synthesis Inhibitors
• 6.3. DNA Synthesis Inhibitors
• 6.4. Mycolic Acid Inhibitors
• 6.5. Protein Synthesis Inhibitors
• 6.6. RNA Synthesis Inhibitors

7. Antibiotics Market, by Drug Class

• 7.1. Introduction
• 7.2. Aminoglycosides
• 7.3. Carbapenem
• 7.4. Cephalosporin
• 7.5. Fluoroquinolone
• 7.6. Macrolides
• 7.7. Penicillin
• 7.8. Sulfonamides

8. Antibiotics Market, by Spectrum

• 8.1. Introduction
• 8.2. Broad-spectrum Antibiotics
• 8.3. Narrow-spectrum Antibiotics

9. Antibiotics Market, by Category

• 9.1. Introduction
• 9.2. Branded Antibiotics
• 9.3. Generic Antibiotics

10. Antibiotics Market, by Application

• 10.1. Introduction
• 10.2. Ear Infection
• 10.3. Gastrointestinal Infections
• 10.4. Respiratory Infections
• 10.5. Septicemia
• 10.6. Skin Infections
• 10.7. Urinary Tract Infections

11. Antibiotics Market, by Route of Administration

• 11.1. Introduction
• 11.2. Oral
• 11.3. Parenteral

12. Antibiotics Market, by Distribution Channel

• 12.1. Introduction
• 12.2. Offline
• 12.3. Online

13. Americas Antibiotics Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Antibiotics Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Antibiotics Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Amneal Pharmaceuticals LLC
• 3. Astellas Pharma, Inc.
• 4. Bausch Health Companies, Inc.
• 5. Bayer AG
• 6. Bristol-Myers Squibb Company
• 7. Cadila Healthcare Ltd.
• 8. Dr. Reddy's Laboratories
• 9. Eli Lilly and Company
• 10. F. Hoffmann-La Roche AG
• 11. Glenmark Pharmaceuticals Limited
• 12. Hetero Healthcare
• 13. Johnson & Johnson Services, Inc.
• 14. KYORIN Holdings, Inc.
• 15. Lupin Limited
• 16. Melinta Therapeutics, Inc.
• 17. Merck & Co., Inc.
• 18. MerLion Pharmaceuticals GmbH
• 19. Mylan N.V. by Viatris
• 20. Novartis International AG
• 21. Pfizer Inc.
• 22. Sanofi S.A.
• 23. Shionogi & Co., Ltd.
• 24. Sun Pharmaceutical Industries Limited
• 25. Teva Pharmaceutical Industries Ltd.